BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for March 17, 2023

March 17, 2023
Biopharmas raising money in public or private financings, including: Alpha Cognition, Dermata, Novan.
Read More

Appointments and advancements for March 17, 2023

March 17, 2023
New hires and promotions in the biopharma industry, including: Avita, Vanda.
Read More

Regulatory actions for March 16, 2023

March 16, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accelus.
Read More

Other news to note for March 16, 2023

March 16, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cardiva Italia, Cyclomics, Embolx, Endoquest Robotics, Oxford Nanopore, Proximie.
Read More

In the clinic for March 16, 2023

March 16, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioventrix, Tandem Diabetes Care.
Read More

Financings for March 16, 2023

March 16, 2023
Med-tech firms raising money in public or private financings, including: Perspectum, Seastar Medical, Spectrumai, Thermogenesis.
Read More

Appointments and advancements for March 16, 2023

March 16, 2023
New hires and promotions in the med-tech industry, including: GT Medical Technologies, Invitae.
Read More

Regulatory actions for March 16, 2023

March 16, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Argenx, Biontech, Bioprojet, Cognition, Deciphera, Edesa, Pfizer, Skye.
Read More

Other news to note for March 16, 2023

March 16, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Artisan, Beigene, Bicycle, Celyad, Concentra, Delsitech, Eton, Gensight, Immunoprecise, Jounce, Libera, Owlstone, Prelude, Summit, Takeda, Talem, TTC Tulex, Yishengbio and YS.
Read More

In the clinic for March 16, 2023

March 16, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bellicum, Cantargia, Dermavant, Direct, Epicentrx, Evecxia, Horizon, Index, Inhibikase, Mabwell, Oryzon, Oxurion, Protagonist, Recode, Stoke.
Read More
Previous 1 2 … 846 847 848 849 850 851 852 853 854 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • New 5-HT2C receptor agonists reported in Hansoh patent

    BioWorld Science
    Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
  • Virtual IPO word with stock graph and arrow

    Parabilis takes top spot, pricing largest biopharma IPO at $670M

    BioWorld
    Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing